Abstract:Alzheimer’s disease (AD) is a progressive neurodegenerative disease that produces disturbances in memory and learning eventually leading to dementia. Responsible for two-thirds of the total cases of dementia in the United States, AD will claim between 3 and 4 million victims by the year 2030 at the present rates of incidence and prevalence. The disease presents with a variable course that ranges from a few years to decades, but which invariably ends in death. Current estimates indicate that over half of the available nursing home beds in this country are now occupied by patients with AD, and the associated economic costs of this disease are staggering. These costs do not consider the emotional toll of the disease on the survivors and caregivers who must witness the slowly vanishing personality and intellect of a family member or close friend. No truly effective treatment exists for this disease although one drug has been approved by the Food and Drug Administration and several more are in clinical trials. Many years of effort and several hundred millions of dollars have been spent researching the causes of AD, and much has been learned in the last 20 years; however, the specific etiology of even one of the many possible forms of AD remains unknown. Approximately 10-15% of clinical cases of AD are of the familial form which has an onset as early as the fourth decade and often has a more rapid course than the non-familial or sporadic type that represents the majority of AD cases and usually has a later age of onset in the sixth and seventh decades. Several genetic loci have now been identified for variants of the familial form of the disease, and the e4 allele of the gene encoding the apolipoprotein E molecule has now been shown to be associated with the late-onset form of AD. What remains unknown is whether and how these genetically different forms of the disease have the same profile of neurochemical deficits during the course of the disease. This is important becauseuntil the molecular precipitant of the disease process(es) is identified and a strategy developed to combat it, a rational treatment of the existing population of patients should be directed toward normalization of the existing neurochemical alterations. Unfortunately, the available research materials do not give a clear or consistent picture of the course of AD in terms of the neurochemical changes at different stages of the disease. These research materials usually take two forms: (1) the postmortem brain from a patient with a clinical history of dementia and neuropathologically confirmed

Gold Nanoparticle-Based Facile Detection of Human Serum Albumin and Its Application As an INHIBIT Logic Gate.

Quantitation, Visualization, and Monitoring of Conformational Transitions of Human Serum Albumin by A Tetraphenylethene Derivative with Aggregation-Induced Emission Characteristics

A Combined Plasmonic and Electrochemical Aptasensor Based on Gold Nanopit Arrays for the Detection of Human Serum Albumin

Neuropeptides and Alzheimer's Disease Pathology

Aptameric System for the Highly Selective and Ultrasensitive Detection of Protein in Human Serum Based on Non-Stripping Gold Nanoparticles

Multiple Signal Amplified Electrochemiluminescent Immunoassay for Hg2+ Using Graphene-Coupled Quantum Dots and Gold Nanoparticles-Labeled Horseradish Peroxidase

Gold Nanoparticles in Serum and Milk and Their Effect for Label-Free Colorimetric Sensing of DNA

Detection of human serum albumin using a rare-earth nanosheet fluorescent probe based on intensity and lifetime signals

Facile biotic/abiotic sandwich detection system for the highly sensitive detection of human serum albumin and glycated albumin

Gold Nanoparticle-Colloidal Carbon Nanosphere Hybrid Material: Preparation, Characterization, and Application for an Amplified Electrochemical Immunoassay

A rapid reduction of Au(I→0) strategy for the colorimetric detection and discrimination of proteins

Naked-eye sensitive ELISA-like assay based on gold-enhanced peroxidase-like immunogold activity

A self-assembled nanoprobe for detecting HSA based on hydrazide Schiff base: Its applications in diseases diagnosis and lysosome targeting imaging

Synthesis of Silver Nanoparticles and Gold Nanoparticles Used as Biosensors for the Detection of Human Serum Albumin-Diagnosed Kidney Disease

Hemoglobin-Promoted Growth of Polyhedral Gold Nanoparticles for the Detection of Glucose, H 2 O 2 , and Ascorbic Acid

A supramolecular ratiometric fluorescent probe for the detection of human serum albumin

A Simple Colorimetric Sensor Based on Anti-Aggregation of Gold Nanoparticles for Hg2+ Detection

HSA over BSA: Selective detection of Human Serum Albumin via a naphtho [2,1‐b] furan‐based system

Aggregation-induced emission enhancement of gold nanoclusters triggered by sodium heparin and its application in the detection of sodium heparin and alkaline amino acids

Effects of Coatings on the Fracture Resistance of Ophthalmic Lenses

A novel TICT-based near-infrared fluorescent probe for light-up sensing and imaging of human serum albumin in real samples